PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Consumer Reports’ Deafening Silence about Safe Foreign Online Pharmacies

Consumer Reports' silence

Back in 2008, Consumer Reports recommended PharmacyChecker to Americans looking to save money on prescription drugs at foreign pharmacies. An article in the Los Angeles Times stated: “Consumer Reports Best Buy Drugs advises checking online prices, for U.S. and foreign pharmacies, at”

That was then. This is now.

When Consumer Reports’ Lisa Gill testified before the Senate Special Committee on Aging hearing on drug prices last week, she was silent in her prepared remarks about what she knows well: millions of Americans, readers of Consumer Reports, buy medicine online internationally. Her silence did not surprise me because Consumer Reports does not currently recommend buying medicine online from Canada or other countries, although many of its readers believe it should.

History of Consumer Reports’ Stance on Foreign Pharmacies

Before we dive in to the history of Consumer Reports and PharmacyChecker, let it be clear that Lisa Gill and others involved with Consumer Reports Best Buy Drugs have done a great job researching and educating consumers about how to save money in the U.S. and should be commended.

It’s also worth noting three notable recommendations for using

Diane Archer, JD, Founder of Just Care, former Chair of the Consumer Reports’ Board of Directors;

Roger Bate, PhD, American Enterprise Institute, economist and expert on counterfeit drugs; and

Elisabeth Rosenthal, MD, Editor and Chief of Kaiser Health News, former reporter for the New York Times.

Now, a timeline:


In 2008, Consumer Reports recommended PharmacyChecker to Americans looking to save money on prescription drugs at foreign pharmacies.


In 2011, Consumer Reports published an article called:

Save money by ordering drugs from Canada? Not so fast.

I was stunned because I knew well the research Consumer Reports was reviewing in putting together the article. The article correctly noted that some foreign online pharmacies, rogue sites, sell counterfeit and substandard medicine. But to make its case, it mentioned peer-reviewed research by Roger Bate of the American Enterprise Institute. Bizarrely, wrongly, Consumer Reports not only failed to cite the author and a link to the research but also failed to communicate that researcher’s conclusion.

Here’s what Roger Bate wrote about Consumer Reports’ article: 

“…it misleads the reader by not explaining the main conclusion of the study. My research team concluded that if one bought from foreign online sellers credentialed by independent group, there was no more demonstrated risk than buying from sites approved in the United States by the National Association of Boards of Pharmacy.”

Mr. Bates’ conclusions were based on actually testing medicines and pharmacy practices. Consumer Reports never conducted any similar type of research, but decided to rely on sources and programs funded by drug companies.


From that article forward, Consumer Reports has toed the line of pharmaceutical industry fearmongering on this issue. Its article from 2015 is indicative of my point:

Is it OK to buy medicine online? Some people get prescription drugs from Internet sites outside of the U.S., but there are safer ways to save

The article looks to Carmen Catizone, PharmD, Executive Director of the National Association of Boards of Pharmacy (NABP), for wisdom. But the NABP’s Internet pharmacy programs are either supported by big chain pharmacies, such as Walgreens and CVS, or funding from pharmaceutical companies – who don’t want the competition of lower foreign drug prices. Consumer Reports states:

“If you choose to order online, make sure that the site is licensed, requires you to submit prescriptions, has a state-licensed pharmacist available to answer questions, and is within the U.S. (You may want to stick with the websites of drugstores you already know and trust, those connected to chain stores, big-box stores, and local mom and pop pharmacies.)”

Consumer Reports goes on to recommend NABP’s programs, including “.Pharmacy” (dot pharmacy), a program whereby an NABP-approved online pharmacy can have “.Pharmacy” in its domain address (i.e. The NABP .Pharmacy program was launched with $300,000 from Eli Lilly, Merck, and Pfizer plus more from other drug companies. The program doesn’t allow any international online pharmacy that fills prescriptions mailed to the U.S. to have “.Pharmacy” at the end of their web address.

Indirect Funding from Pfizer

To add insult to injury, and ironically, much of Consume Reports’ reporting on this issue is, indirectly, funded by Pfizer. At the end of that 2011 article mentioned above, it reads:

“This article and related materials are made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program, which is funded by the multistate settlement of consumer-fraud claims regarding the marketing of the prescription drug, Neurontin (gabapentin).”

That settlement was with Pfizer. That money is going toward educating the public about online pharmacies exactly how Pfizer would like it to be done.

Consumer Reports’ Readers Smell Something Fishy

How did Consumer Reports’ readers respond? Here are a few excerpts:

David Slobodin: “I agree with many of the previous writers. This article is the worst one I have seen from CRs in the 50 or so years that I have been reading it… ordered the drug from [REDACTED]. One hundred pills cost $80, or about 1/10 of the price, here. The drugs are effective.”

“…If CR wants to do their readers a service, rathr than the disservice provided by this article, they should order a variety of Canadian drugs and do chemical tests to determine if they are the same as their US counterparts.”

Arthur Powers: “I am a strong supporter of Consumer Reports, but I feel that this article is a disservice. What they should be doing is identifying the Canadian (or UK or other) sites that are legitimate rather than putting out a blanket statement that we shouldn’t buy from such sites.”

Rob Garneau: “i’m disappointed in Consumer Reports for following the government broad brush recommendation to avoid international drugs which further protects the big profits of drug companies. There are plenty of reputable international drug sites from which I’ve been buying drugs for years without issue…Check out which verifies international sites and provides prices.”

Consumers Union, the advocacy arm of Consumer Reports, supports legislation to make importation of lower-cost prescription drugs legal – among many policies to lower drug prices here in America. All good. But they can still tell the truth…better…about international online pharmacies. Their readers deserve it – and that’s what they want.

To hammer this home, there was a Part I of the hearing on drug prices before the Senate Special Committee on Aging, the day before the one in which Ms. Gill testified. The witnesses were all patients struggling with drug costs. Sen. Bob Casey (D-PA) asked them all if they support importing lower-cost, safe and effective medications [See 1:07:49 on the video]. All were in favor, and two said they know people who already import.

Since everybody knows that people who access more affordable medicines from licensed pharmacies in other countries are finding relief: ignoring that – or publishing Big Pharma’s (or even the FDA’s) advice – does not help patients who can’t afford medicine.

Tagged with: ,

FDA’s Misplaced Advice to Patients in CanaRx Import Warning

Last week, in a warning letter and press release, the FDA went to great lengths to demonize what appears to be an exceedingly safe personal prescription drug importation program offered by a Canadian company called CanaRx Services, Inc. I believe the agency crossed the line with bad advice to patients. In a nutshell, about 500 U.S. cities, companies, and other organizations use CanaRx to offer their employees and retirees a lower-cost international pharmacy option. The prescription medicines are mailed from licensed pharmacies in Canada, Australia and the United Kingdom to U.S. consumers. CanaRx’s programs have been in effect for almost 20 years and helped taxpayers and patients save $250 million, according to the company.

Tagged with: , , ,

NY State Authorizes Paper Prescriptions to Fill in Foreign Pharmacies

Good news for New Yorkers who want freedom of choice to fill their prescriptions at pharmacies located where they are more affordable: in other countries. There is now an explicit exception to the electronic prescription (e-prescribing) law in New York that permits paper prescriptions to be filled in other countries. I’m sorry we didn’t catch this earlier, but here it is now. As of January 2017, according to the NY State Department of Health, one exception to e-prescribing, which allows a provider to write a paper prescription, is when the medicine is: 

“…dispensed by a pharmacy located outside the state, outside the country, or on federal property, including and not limited to the following examples; Veterans Administration, West Point, Fort Drum, and Indian Reservations;”

When e-prescribing became mandatory in NY, people had a hard time obtaining paper prescriptions. This was not just an inconvenience. It was a threat to their access to affordable medicine. In our country, it’s sometimes imperative to shop around and find the pharmacy that charges the lowest price in our neighborhood – or in another country. This development should be very helpful to people looking to shop around.

Tagged with: ,

Drug Prices are High because Big Pharma Dresses Wolves in Sheep’s Clothing

This week, Wendell Potter, healthcare advocate and publisher of non-profit media outlet Tarbell, called out a slew of drug industry experts for undermining efforts to lower drug prices. This includes the likes of Sally Pipes of the Pacific Research Institute, the Alliance for Safe Online Pharmacies, and the Partnership for Safe Medicines. All use the specter of counterfeit drugs and the opioid crisis to scare the American public away from safe personal importation via online pharmacies.

Recipients of Drug Company Donations

Who is called out?

  1. Sally Pipes, from the Pacific Research Institute, because in an op-ed opposing drug importation, Ms. Pipes obtusely connects Americans ordering drugs from Canada with the many tragic deaths in low-income countries from counterfeit drugs.
  2. The Alliance for Safe Online Pharmacies (ASOP) for peddling false information about World Health Organization studies and counterfeit drugs.
  3. The Partnership for Safe Medicines (PSM) for using the opioid crisis as a tool to oppose importation of regular, less expensive prescription medicine.
Tagged with: , , ,

The Mike Enzi Foundation for Lower-Cost Imported Insulin Should Exist

Senator Mike Enzi

In my blog post about the Senate Finance Committee hearing on drug prices, I noted my surprise at Senator Mike Enzi’s (R-WY) comment that he knew about a foundation that helps people import lower-cost insulin from Canada. Sen. Enzi stated that a person referred to as his diabetes advisor had “found a way to work through a foundation to import insulin for a number of people at lower-cost. And I think he worked for a foundation so that it would be legal.” I had endeavored to look into it, but fortunately Jay Hancock from Kaiser Health News beat me to it and found, sadly, no such insulin import program exists. I think we can all agree that it should!

In researching the story, Jay asked me if I knew of such a program.


Tagged with: ,

Bing is Promoting Dangerous Online Pharmacies, Says New Study

Bing is Promoting Dangerous Online Pharmacies, Says New Study

According to a new study published by the American Enterprise Institute, the search engine Bing, which is operated by Microsoft, is encouraging web searchers to click to rogue online pharmacies that are more likely to sell counterfeit drugs. As the reports shows, Bing’s action appears to purposefully thwart safe personal importation of more affordable medicines. It is one of the clearest examples of censorship resulting from “voluntary agreements” among Internet companies, “encouraged” by regulators, that will threaten the health of patients buying medicine online under the guise of protecting them. Bing has placed warnings on its organic search results of safe Canadian-based and other international online pharmacies, yet the search engine fails to do so for many rogue websites, ones proven to sell counterfeit drugs. Here’s how that happened.

Bing’s problem is its use of the National Association of Boards of Pharmacy’s (NABP) Not Recommended List (NRL). Many of the NABP’s programs involving online sales of medicines and educating the public about online pharmacies are funded by drug companies, and therefore supportive of the industry’s profit-protecting goals against importation.

Bing’s Backwards Partnership with the NABP

Tagged with: , , , ,